Treatments
Stanford cardiologists are world leaders in the development of implantable cardioverter defibrillator (ICD) devices. Our cardiac surgeons are pioneers in the development of the myectomy/myotomy.
Many patients with hypertrophic cardiomyopathynever need treatment. However, it is imperative for all patients to be monitored by a cardiologist. A cardiologist will work with the patient to determine an individualized plan for monitoring, medical therapy, intervention and follow-up.
The patient will communicate with the healthcare provider to determine treatment options based on factors such as:
- Age
- Overall health
- Medical history
- Extent of the disease
- Tolerance for specific medications, procedures, or therapies
- Expectations for the course of the disease
Learn more about the following treatment options for hypertrophic cardiomyopathy: